Gary Jacob
Vermogen: 186 798 $ op 31-05-2026
Vermogen: 186 798 $ op 31-05-2026
Gary S.
Jacob is the founder.
Dr. Jacob is also the founder of Synergy Pharmaceuticals LLC.
Founding positions included Chairman, President & Chief Executive Officer at Synergy Pharmaceuticals, Inc. (2008-2017).
Current jobs include Chief Executive Officer & Executive Director at OKYO Pharma Ltd. (2021-present) and Independent Director at Actavia Life Sciences, Inc. (2020-present).
Former jobs include President, Chief Executive Officer & Director at Callisto Pharmaceuticals, Inc. (2004-2013), President, Chief Executive Officer & Director at Pawfect Foods, Inc. (2008), CEO, Non-Executive Director & Managing Director at Immuron Ltd. (2019-2020), Chairman at Hepion Pharmaceuticals, Inc. (2014-2024), Chairman at Synergy DE (2008), Director-Functional Genomics, Science & Technology at Monsanto Co. (1997-1998), Independent Director at Cardiff Oncology, Inc. (2012-2021), Glycobiology Director at G.D.
Searle LLC (1990-1997), Independent Director at Virpax Pharmaceuticals, Inc. (2020-2022), and Manager-Searle Glycobiology Group at the University of Oxford (1990).
Education includes a doctorate from the University of Wisconsin and an undergraduate degree from the University of Missouri-St. Louis.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
OKYO PHARMA LIMITED 0,21% | 18-03-2026 | 108.920 ( 0,21% ) | 186 798 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ACTAVIA LIFE SCIENCES, INC. | Directeur/Bestuurslid | 23-12-2020 |
| WEST AFRICAN MINERALS CORP | Directeur/Bestuurslid | 07-01-2021 |
| Bedrijven | Functie | Einde |
|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Algemeen Directeur | 19-03-2014 |
| VIRPAX PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 25-07-2022 |
| IMMURON LIMITED | Algemeen Directeur | 25-03-2020 |
| SYNERGY PHARMACEUTICALS INC | Algemeen Directeur | 19-12-2017 |
Synergy Pharmaceuticals, Inc. /Old/
Synergy Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Researches and develops drugs to treat hepatitis C, hepatitis B, epilepsy and brain cancer | Algemeen Directeur | 01-10-2017 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 16 |
|---|---|
Monsanto Co.
Monsanto Co. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company controlling insects and weeds & manufactures seeds and genomics | Commercial Services |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops novel therapeutics to treat cancer | Health Technology |
Pawfect Foods, Inc.
Pawfect Foods, Inc. Specialty StoresRetail Trade Sells pet food via the internet | Retail Trade |
OKYO Pharma Ltd.
OKYO Pharma Ltd. BiotechnologyHealth Technology Develops next-generation therapeutics to improve the lives of patients suffering from inflammatory eye diseases | Health Technology |
Hepion Pharmaceuticals, Inc.
Hepion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapy for treatment of chronic liver diseases | Health Technology |
Synergy Pharmaceuticals, Inc. /Old/
Synergy Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Researches and develops drugs to treat hepatitis C, hepatitis B, epilepsy and brain cancer | Health Technology |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cardiff Oncology, Inc.
Cardiff Oncology, Inc. Medical SpecialtiesHealth Technology Develops diagnostic products | Health Technology |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immuron Ltd.
Immuron Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Synergy Pharmaceuticals LLC
Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops drugs to treat gastrointestinal disorders and diseases | Health Technology |
G.D. Searle LLC | |
Synergy DE | |
University of Missouri-St. Louis
University of Missouri-St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actavia Life Sciences, Inc.
Actavia Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Virpax Pharmaceuticals, Inc.
Virpax Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical-stage pharmaceutical company that develops non-addictive pain and neurological disorders | Commercial Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau